Phytonadione NDC 67046-1581

NDC codes

FDA NDC Directory

Product NDC (as listed)67046-1581Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67046-1581Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67046-1581-3	67046158103	30 TABLET in 1 BLISTER PACK (67046-1581-3)Marketed from Sep 8, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phytonadione
Generic name (nonproprietary): phytonadione
Active ingredients: Phytonadione — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Coupler LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210189
Marketing start: Sep 8, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Increased Prothrombin Activity (Physiologic effect)Reversed Anticoagulation Activity (Physiologic effect)Vitamin K (Chemical structure)
Identifiers: Product ID 67046-1581_3e4f86c4-7e70-c864-e063-6394a90a59afSPL ID 3e4f86c4-7e70-c864-e063-6394a90a59afSPL set ID 3e4f86c4-7e89-c864-e063-6394a90a59afRxCUI 198102UNII A034SE7857
Pharmacologic class: Vitamin K; Warfarin Reversal Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467046158103 followed by a unit qualifier and the quantity

Package 67046-1581-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 8, 2025.

Indications (excerpt from the label)

Phytonadione is indicated for the treatment of adults with the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity. anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; hypoprothrombinemia secondary to antibacterial therapy; hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancrease, and regional enteritis; Other drug-induced hypoprothrombinemia where it is definitely sh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210189

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210189
Product	Strength	Form · route	Labeler	Product NDC
Phytonadione	Phytonadione 5 mg/1	TabletOral	Safecor Health, LLC	48433-160
Phytonadione	Phytonadione 5 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1014
Phytonadione	Phytonadione 5 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1318
Phytonadione	Phytonadione 5 mg/1	TabletOral	Northstar Rx LLC.	16714-973